Detection of catheter-related bloodstream infections by the Gram stain-acridine orange leukocyte cytospin test in hematopoietic stem cell transplant recipients

被引:3
|
作者
Abdelkefi, A [1 ]
Achour, W [1 ]
Torjman, L [1 ]
Ben Othman, T [1 ]
Ladeb, S [1 ]
Lakhal, A [1 ]
Allouche, H [1 ]
Ben Hassen, A [1 ]
Ben Abdeladhim, A [1 ]
机构
[1] Ctr Natl Greffe Moelle Osseuse, Tunis, Tunisia
关键词
Gram stain-acridine orange leukocyte cytospin; central venous catheter; catheter-related bloodstream infection; hematopoietic stem cell transplantation;
D O I
10.1038/sj.bmt.1705293
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
In patients with central venous catheters (CVCs), catheter-related bloodstream infections (CRBI) are a prominent cause of morbidity, excess hospital costs, and in some cases mortality. The aim of this prospective study was to assess the validity of the Gram stain-acridine orange leukocyte cytospin (AOLC) test for the diagnosis of CRBI in hematopoietic stem cell transplant (HSCT) recipients with nontunnelled CVCs, using the differential-time-to-positivity (DTP)/clinical criteria as the criterion standard to de. ne CRBIs. CVCs were externalized, nontunnelled, polyurethane double lumen catheters (Arrows, Readings, USA). All CVCs were placed in the subclavian vein by the infraclavicular approach, in the operating room. Catheters were inserted percutaneously, using the Seldinger technique. Study catheters were not exchanged over guidewires. Between May 2002 and December 2004, a total of 245 consecutive patients were included. Twenty-six of the 245 patients (10.6%) had CRBI as determined by the DTP method. The Gram stain-AOLC was positive in only two patients (7.6%) with a CRBI. Our results suggest that the Gram stain AOLC test is not useful for the diagnosis of catheter-related bloodstream infection in HSCT recipients.
引用
收藏
页码:595 / 599
页数:5
相关论文
共 42 条
  • [21] Catheter-related complications in patients with acute myeloid leukemia after hematopoietic stem cell transplant
    Khalil, Mohammad O.
    Pierson, Namali
    Selby, George B.
    Cherry, Mohamad
    Holter, Jennifer L.
    JOURNAL OF VASCULAR ACCESS, 2015, 16 (02): : E10 - E10
  • [22] Bloodstream Infections and Delayed Antibiotic Coverage Are Associated With Negative Hospital Outcomes in Hematopoietic Stem Cell Transplant Recipients
    Ji, Joyce
    Klaus, Jeff
    Burnham, Jason P.
    Michelson, Andrew
    McEvoy, Colleen A.
    Kollef, Marin H.
    Lyons, Patrick G.
    CHEST, 2020, 158 (04) : 1385 - 1396
  • [23] Preventive strategies for central line-associated bloodstream infections in pediatric hematopoietic stem cell transplant recipients
    Barrell, Catherine
    Covington, Lisa
    Bhatia, Monica
    Robison, Jeff
    Patel, Sangita
    Jacobson, Judith S.
    Buet, Amanda
    Graham, Philip L.
    Saiman, Lisa
    AMERICAN JOURNAL OF INFECTION CONTROL, 2012, 40 (05) : 434 - 439
  • [24] CATHETER-RELATED INFECTIONS IN PATIENTS SUBMITTED TO HEMATOPOIETIC STEM CELL TRANSPLANTATION. SINGLE CENTER STUDY
    Batlle, Montserrat
    Triguero, Anna
    Morgades, Mireia
    Gimenez, Montserrat
    Jose Jimenez, Ma
    Serrate, Edurne
    Sitges, Marta
    Pena, Marta
    Ferra, Christelle
    Manuel Sancho, Juan
    Moreno, Miriam
    Xicoy, Blanca
    Vives, Susana
    Torrent, Anna
    Ma Ribera, Josep
    BONE MARROW TRANSPLANTATION, 2018, 53 : 543 - 544
  • [25] CENTRAL VENOUS CATHETER-RELATED BLOOD STREAM INFECTIONS IN CHILDREN UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANT FOR PRIMARY IMMUNODEFICIENCY AND OTHER NONMALIGNANT DISORDERS
    Cole, Theresa S.
    Rogerson, Elizabeth
    Collins, Jennifer
    Galloway, Angela
    Clark, Julia
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (12) : 1098 - 1100
  • [26] Microbiology and Risk Factors for Hospital-Associated Bloodstream Infections Among Pediatric Hematopoietic Stem Cell Transplant Recipients
    Akinboyo, Ibukunoluwa C.
    Young, Rebecca R.
    Spees, Lisa P.
    Heston, Sarah M.
    Smith, Michael J.
    Chang, Yeh-Chung
    McGill, Lauren E.
    Martin, Paul L.
    Jenkins, Kirsten
    Lugo, Debra J.
    Hazen, Kevin C.
    Seed, Patrick C.
    Kelly, Matthew S.
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (04):
  • [27] The incidence of catheter-related infections from day 0 to day 100 in allogeneic stem cell transplant patients
    Berthelsen, A
    Laursen, H
    Lanther, T
    Holder, J
    Rasmussen, S
    Heilmann, C
    BONE MARROW TRANSPLANTATION, 2004, 33 : S265 - S265
  • [28] Reduction of catheter-related bloodstream infections by use of rifampicin/minocycline-impregnated CVCs in patients with leukemia and stem cell transplantation
    San Nicolo, K.
    Krause, S. W.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 162 - 162
  • [29] Risk of serious bloodstream infections is low in pediatric hematopoietic stem cell transplant (HSCT) recipients with fevers due to antithymocyte globulins and alemtuzumab
    Horn, B.
    O'Kane, S.
    Wattier, R. L.
    Wahlstrom, J. T.
    Melton, A.
    Cowan, M. J.
    Dvorak, C. C.
    BONE MARROW TRANSPLANTATION, 2016, 51 (11) : 1510 - 1512
  • [30] Risk of serious bloodstream infections is low in pediatric hematopoietic stem cell transplant (HSCT) recipients with fevers due to antithymocyte globulins and alemtuzumab
    B Horn
    S O'Kane
    R L Wattier
    J T Wahlstrom
    A Melton
    M J Cowan
    C C Dvorak
    Bone Marrow Transplantation, 2016, 51 : 1510 - 1512